# Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers

> **NCT02046551** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Yale University**

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02046551
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding lost
- **Last updated:** 2017-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046551, "Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02046551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*